Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Current Accrued Expense : $0.67 Mil (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Zhong Yuan Bio-Technology Holdings Current Accrued Expense?

Zhong Yuan Bio-Technology Holdings's Current Accrued Expense for the quarter that ended in Sep. 2023 was $0.67 Mil.

Zhong Yuan Bio-Technology Holdings's quarterly Current Accrued Expense increased from Sep. 2022 ($0.15 Mil) to Mar. 2023 ($0.45 Mil) and increased from Mar. 2023 ($0.45 Mil) to Sep. 2023 ($0.67 Mil).

Zhong Yuan Bio-Technology Holdings's annual Current Accrued Expense increased from Mar. 2021 ($0.10 Mil) to Mar. 2022 ($0.16 Mil) and increased from Mar. 2022 ($0.16 Mil) to Mar. 2023 ($0.45 Mil).

Zhong Yuan Bio-Technology Holdings Current Accrued Expense Historical Data

The historical data trend for Zhong Yuan Bio-Technology Holdings's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhong Yuan Bio-Technology Holdings Current Accrued Expense Chart

Zhong Yuan Bio-Technology Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Mar19

Mar20

Mar21

Mar22

Mar23

Current Accrued Expense

Get a 7-Day Free Trial

0.15

0.07

0.10

0.16

0.45

Zhong Yuan Bio-Technology Holdings Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Current Accrued Expense	Get a 7-Day Free Trial								0.09	0.16	0.15	0.45	0.67

Zhong Yuan Bio-Technology Holdings Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Zhong Yuan Bio-Technology Holdings Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Zhong Yuan Bio-Technology Holdings's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Zhong Yuan Bio-Technology Holdings Ltd (OTCPK:ZHYBF) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

28 Queen’s Road East, Suite 901, Tesbury Centre, Wanchai, Hong Kong, HKG

Website

https://www.zybioholdings.com

Zhong Yuan Bio-Technology Holdings Ltd is engaged in the business of developing and marketing nervonic acid-based health supplements and sales of acer truncatum seedlings. The company has two reportable segments such as sales of health care supplements and technical supporting services. The company generates its revenue primarily from the sales of health care supplements.

Executives

Tingting Chang	director, 10 percent owner, officer: CEO	RM 1002, 10THFL, LONG HU FUTURE OFFICE, NO. 1 EAST SHI LI PU ROAD, CHAO YANG DISTRICT, BEIJING F4 100024
James M Cassidy	director, 10 percent owner, officer: president,secretary,treasurer	215 APOLENA AVENUE, NEWPORT BEACH CA 92662
James K Mckillop	director, 10 percent owner, officer: Vice President	9454 WILSHIRE BOULEVARD, SUITE 612, BEVERLY HILLS CA 90212

Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Headlines

No Headlines